Exercise Strategies in Parkinson's Disease
Implementation of Exercise Strategies in Parkinson's Disease: Clinical Outcomes
2 other identifiers
interventional
288
1 country
3
Brief Summary
The goal of this clinical trial is to learn about exercise and physical activity people with Parkinson's Disease. The main questions it aims to answer are: 1) learn about the physical activity and exercise behaviors of people with Parkinson's Disease over the course of a year and 2) compare 3 exercise guidance strategies aimed to impact exercise behavior: standard care, written exercise guidance from neurologist and/or physical therapy. During the course of the study:
- 1.Participants will use activity trackers and a mobile phone application to monitor their exercise participation.
- 2.At the same time, the research team will be working with the participant's medical teams at Northwestern Medicine and University of Chicago Medical Center to improve the way that they deliver exercise guidance using verbal instructions and encouragement, written exercise guidance, and/or physical therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable parkinson-disease
Started Mar 2024
Longer than P75 for not_applicable parkinson-disease
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2023
CompletedFirst Posted
Study publicly available on registry
October 27, 2023
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2028
April 20, 2026
April 1, 2026
4.3 years
October 23, 2023
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accelerometer Measures
Minutes per day of moderate to vigorous physical activity (MVPA)
Average 1-week MVPA measured every 3-months throughout 12-month study period
Secondary Outcomes (1)
Steps per Day
Average 1-week step counts measured every 3-months throughout 12-month study period
Study Arms (3)
Standard Care
NO INTERVENTIONStandard care patient's with Parkinson's Disease are receiving at each site.
Written exercise guidance by neurologist
ACTIVE COMPARATORNeurologists will provide written exercise education and guidance to their patients with Parkinson's Disease.
Physical therapy
EXPERIMENTALA consultative model of physical therapy will be implemented at each site for patient's with Parkinson's Disease.
Interventions
Neurologists will provide written exercise education and guidance to their patients with Parkinson's Disease during neurologist visits and/or in after visit summary in the patient's EMR patient portal. The research team will facilitate the development of the written exercise guidance with input and feedback from each site's neurology, clinical, and administrative teams.
A consultative model of physical therapy - a lower dose of physical therapy focused on physical activity and exercise promotion and coaching - will be implemented into each site. In the consultative model of physical therapy, visits are scheduled around needs of the patient, however will involve 1-4 additional visits within 3 months of evaluation and is based on personal factors that influence their exercise prognosis such as self-efficacy, readiness to change, fitness level, age, health literacy, comorbidities, and Parkinson's Disease-related motor and non-motor impairments.
Eligibility Criteria
You may qualify if:
- Have a neurologist confirmed diagnosis of Parkinson's Disease
- Hoehn\&Yahr Stage 1-3
- Age 18-89 years old
- Ambulatory
- Written and verbal basic English proficiency adequate for survey completion
- Have a smart phone
- Willing to sync activity tracker with Datos health app at least every 3 days
- Willing to accept Datos' Terms and Conditions
You may not qualify if:
- Diagnosis of dementia or mild cognitive impairment in medical record
- Uses a rollator or rolling walker for mobility
- Other comorbidities significantly limiting ability to participate in exercise \>12 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shirley Ryan AbilityLablead
- University of Chicagocollaborator
- Northwestern Medicinecollaborator
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator
Study Sites (3)
Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Northwestern Medicine
Lake Forest, Illinois, 60045, United States
Related Publications (3)
Osborne JA, Botkin R, Colon-Semenza C, DeAngelis TR, Gallardo OG, Kosakowski H, Martello J, Pradhan S, Rafferty M, Readinger JL, Whitt AL, Ellis TD. Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From the American Physical Therapy Association. Phys Ther. 2022 Apr 1;102(4):pzab302. doi: 10.1093/ptj/pzab302. Erratum In: Phys Ther. 2022 Aug 1;102(8):pzac098. doi: 10.1093/ptj/pzac098.
PMID: 34963139BACKGROUNDRafferty MR, MacDonald J, Byskosh A, Sloan L, Toledo S, Marciniak C, Simuni T. Using Implementation Frameworks to Provide Proactive Physical Therapy for People With Parkinson Disease: Case Report. Phys Ther. 2019 Dec 16;99(12):1644-1655. doi: 10.1093/ptj/pzz129.
PMID: 31508801BACKGROUNDCavanaugh JT, Ellis TD, Earhart GM, Ford MP, Foreman KB, Dibble LE. Capturing ambulatory activity decline in Parkinson's disease. J Neurol Phys Ther. 2012 Jun;36(2):51-7. doi: 10.1097/NPT.0b013e318254ba7a.
PMID: 22592060BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miriam Rafferty, PT, DPT, PhD
Shirley Ryan AbilityLab
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Implementation Science
Study Record Dates
First Submitted
October 23, 2023
First Posted
October 27, 2023
Study Start
March 1, 2024
Primary Completion (Estimated)
May 31, 2028
Study Completion (Estimated)
May 31, 2028
Last Updated
April 20, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP
- Time Frame
- Data will become available following completion and analysis of research study data. Data will be stored in our laboratory data repository system and thus will be available indefinitely.
- Access Criteria
- Data summaries will be publicly available on the Shirley Ryan AbilityLab website and Northwestern University DigitalHub. De-identified data will, also, be shared in the Data and Specimen Hub (DASH) through the NICHD.
In accordance with the "NICHD Plans for Sharing Human and Non-Human Data and/or Biospecimens" policy, resulting data will be shared in the Data and Specimen Hub (DASH) in de-identified format. Our research results will also be made available to the public via summaries on the Shirley Ryan AbilityLab (SRAlab) website and Northwestern University's DigitalHub, a repository for scholarly output through Northwestern University developed by Galter Health Sciences Library (Northwestern).